Hepatotoxicidad inducida por amoxicilina-ácido clavulánico con evolución a cirrosis
Authors:
- T. JordánTJT. Jordán
- M. GonzálezMGM. González
- M. CasadoMCM. Casado
- J.F. SuárezJSJ.F. Suárez
- J. EstebanJEJ. Esteban
- F. PulidoFPF. Pulido
- E. GuerreroEGE. Guerrero
- 1 January 2002
- journal article
- case report
- Published by Elsevier in Gastroenterología y Hepatología
- Vol. 25 (4) , 240-243
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Co-amoxiclav jaundice: clinical and histological features and HLA class II associationGut, 2000
- DRUG-INDUCED LIVER DISEASEMedical Clinics of North America, 2000
- Ursodeoxycholic acid (UDCA) for the treatment of amoxycillin-clavulanate potassium (Augmentin®)-induced intra-hepatic cholestasisEuropean Journal of Gastroenterology & Hepatology, 2000
- Drug-induced liver diseasesJournal of Hepatology, 2000
- Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acidArchives of internal medicine (1960), 1996
- Ursodeoxycholic acid for the treatment of fluchoxacillin-associated cholestasisJournal of Hepatology, 1995
- Liver injury related to amoxycillin-clavulanic acid: interlobular bile-duct lesions and extrahepatic manifestationsJournal of Hepatology, 1995
- Antibiotic-associated acute vanishing bile duct syndrome: A pattern associated with severe, prolonged, intrahepatic cholestasisJournal of Hepatology, 1994
- Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases.Gut, 1992
- Criteria of drug-induced liver disordersJournal of Hepatology, 1990